Maria Luisa Faquetti (Maria L Faquetti)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Venous Thromboembolism

Rheumatoid Arthritis Patients

Top Venues

Pharmacoepidemiology and drug safety

Alzheimer's & dementia (New York, N. Y.)

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Luisa Faquetti, Laura Slappendel, Hélène Bigonne, Francesca Grisoni, Petra Schneider, Georg Aichinger, Gisbert Schneider, Shana J Sturla, Andrea Michelle Burden
Baricitinib and tofacitinib off-target profile, with a focus on Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 10 (1) (2024)
Maria Luisa Faquetti, Laura Slappendel, Hélène Bigonne, Francesca Grisoni, Petra Schneider, Georg Aichinger, Gisbert Schneider, Shana J Sturla, Andrea Michelle Burden
Baricitinib and tofacitinib off-target profile, with a focus on Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.) 10 (1) (2024)
Maria Luisa Faquetti, Géraldine Frey, Dominik Stämpfli, Stefan Weiler, Andrea Michelle Burden
Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care. British journal of clinical pharmacology (2024)
Maria Luisa Faquetti, Géraldine Frey, Dominik Stämpfli, Stefan Weiler, Andrea Michelle Burden
Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care. British journal of clinical pharmacology 90 (6) (2024)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety 32 (3) (2023)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety 32 (3) (2023)
Maria Luisa Faquetti, Enriqueta Vallejo-Yagüe, René Cordtz, Lene Dreyer, Andrea Michelle Burden
JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register. PloS one 18 (7) (2023)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety 32 (3) (2023)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea M Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: a novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety (2022)
Maria Luisa Faquetti, Adrian Martinez-De la Torre, Theresa Burkard, Guillaume Obozinski, Andrea Michelle Burden
Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining. Pharmacoepidemiology and drug safety (2022)